Have you ever wanted to know the PFAS levels in your body? Quest Health is making them widely available, calling them the first-ever consumer-initiated PFAS test.

Quest Diagnostics unveiled a first-to-market blood test for consumers that helps assess the potential risk of developing Alzheimer’s disease.

Quest Diagnostics unveiled a first-to-market blood test available for consumer purchase that detects and measures the level of PFAS.

Advances in drug treatments for Alzheimer’s disease have opened doors for diagnostics, and Quest is the latest to walk through. The clinical testing giant has put forward a blood test designed ...

Test to be available for clinical and research use as soon as this summer, building on Quest's pioneering blood-based AD-Detect™ product line for assessing symptomatic patients SECAUCUS, N.J ...

Quest acquired the test, which detects circulating tumor DNA in blood to detect residual disease in colorectal cancer patients, when it bought Haystack Oncology in 2023.

HOLX's Genius digital cytology system and global rollout position its Cytology unit for long-term growth despite near-term headwinds.